Service members deserve to be treated with effective, innovative care. Even if the treatments seem shocking.

Earlier this month Dan Crenshaw spoke at the House Armed Services Committee to push for further research on the use of psychedelics for active-duty service members. Studies and personal testimonials show the same thing: Ibogaine for PTSD treatment works.

Close friends of his, who have suffered trauma and PTSD, have turned to psychedelic treatments. It’s changed their lives, relationships, and put them on a path to live after devastating trauma.

PTSD is the fourth highest service-connected disability, with more than 1.2 million veterans receiving compensation for PTSD. We can’t grow complacent. We should encourage any and all innovation that will help especially when it can save the lives of our active-duty service members.

After putting their lives on the line for our country, they deserve that much.